FIRST ON FOX: Food and Drug Administration (FDA) commissioner nominee Dr. Heidi Overton has committed to establishing a binding timeline and clear parameters for a safety study on the abortion medication mifepristone , the office of Sen. Josh Hawley, R-Mo., told Fox News Digital on Friday.
Hawley, a member of the Senate Health, Education, Labor and Pensions (HELP) Committee, has spent months pressing federal health officials for accountability over the delayed assessment.
"These are major pro-life wins that help ensure a robust study and the potential reinstatement of critical safeguards on the abortion drug that President Biden stripped…
Read the full article at FOXNEWS.COM












